Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$149M |
| 2 |
NVIDIA
NVDA
|
+$102M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$89.1M |
| 4 |
Comcast
CMCSA
|
+$71.1M |
| 5 |
Progressive
PGR
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$83.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$76.9M |
| 3 |
Coca-Cola
KO
|
+$56.4M |
| 4 |
Broadcom
AVGO
|
+$49.5M |
| 5 |
Lam Research
LRCX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.82% |
| 2 | Healthcare | 20.59% |
| 3 | Consumer Discretionary | 12.23% |
| 4 | Financials | 6.67% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Brookfield Asset Management
BAM
$83.8B
| $2.63M | 0.01% |
65,259
+11,496
| +21% | +$389K |
|
477
Clarivate
CLVT
$1.16B
| $2.58M | 0.01% |
278,396
-16,141
| -5% | -$119K |
|
478
Carter's
CRI
$1.47B
| $2.57M | 0.01% |
34,265
+859
| +3% | +$59.6K |
|
|
PDCO
479
DELISTED
Patterson Companies, Inc.
PDCO
| $2.55M | 0.01% |
89,459
-12,877
| -13% | -$379K |
|
480
Sarepta Therapeutics
SRPT
$1.77B
| $2.54M | 0.01% |
26,388
-24,076
| -48% | -$2.31M |
|
481
Allegion
ALLE
$14.4B
| $2.53M | 0.01% |
+19,960
| New | +$2.13M |
|
482
Xylem
XYL
$28.1B
| $2.52M | 0.01% |
22,056
-834
| -4% | -$83.2K |
|
483
Salesforce
CRM
$158B
| $2.51M | 0.01% |
9,523
+696
| +8% | +$158K |
|
484
Mercado Libre
MELI
$92.3B
| $2.47M | 0.01% |
1,570
| – | – |
|
485
Western Union
WU
$2.21B
| $2.45M | 0.01% |
205,399
+11,152
| +6% | +$136K |
|
486
Idacorp
IDA
$8.2B
| $2.44M | 0.01% |
+24,842
| New | +$2.41M |
|
487
Carlisle Companies
CSL
$15.4B
| $2.44M | 0.01% |
7,797
-20,654
| -73% | -$5.69M |
|
488
MGP Ingredients
MGPI
$375M
| $2.42M | 0.01% |
24,537
-2,396
| -9% | -$230K |
|
489
CorVel
CRVL
$3.19B
| $2.39M | 0.01% |
28,992
-3,441
| -11% | -$244K |
|
|
IPG
490
DELISTED
Interpublic Group of Companies
IPG
| $2.37M | 0.01% |
72,739
-39,648
| -35% | -$1.19M |
|
491
Chegg
CHGG
$102M
| $2.37M | 0.01% |
208,806
+96,609
| +86% | +$917K |
|
|
DO
492
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $2.35M | 0.01% |
+180,630
| New | +$2.33M |
|
493
BCE
BCE
$21.2B
| $2.35M | 0.01% |
59,278
+9,833
| +20% | +$381K |
|
494
Watsco Inc
WSO
$13.6B
| $2.32M | 0.01% |
5,411
+3,836
| +244% | +$1.49M |
|
495
Li Auto
LI
$12.7B
| $2.31M | 0.01% |
+61,722
| New | +$2.23M |
|
496
Franco-Nevada
FNV
$46B
| $2.3M | 0.01% |
20,653
+10,669
| +107% | +$1.3M |
|
497
MGIC Investment
MTG
$6.25B
| $2.29M | 0.01% |
118,864
-87,818
| -42% | -$1.55M |
|
498
ICU Medical
ICUI
$4.61B
| $2.25M | 0.01% |
22,534
+17,769
| +373% | +$1.74M |
|
499
Ingles Markets
IMKTA
$1.67B
| $2.19M | 0.01% |
25,319
-2,589
| -9% | -$211K |
|
500
Accenture
ACN
$108B
| $2.18M | 0.01% |
+6,216
| New | +$2M |
|
Similar funds
Ray Dalio's Q4 2023 Portfolio in Review
As of Q4 2023, Ray Dalio held 827 positions worth $17.9B, up 8% from $16.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ray Dalio's Q4 2023 filing shows 87 new, 260 increased, 385 reduced and 85 closed positions. Its largest new stake was iShares MSCI Brazil ETF: 2,750,734 shares worth $96.2M. The largest sale was Costco, an estimated $83.3M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ray Dalio's largest Q4 2023 buy was iShares MSCI Brazil ETF: 2,750,734 shares worth $96.2M.
- Ray Dalio added most to Eli Lilly in Q4 2023, an estimated $149M increase.
- Ray Dalio's biggest Q4 2023 reduction was Costco, cutting an estimated $83.3M.
- Ray Dalio fully exited Netflix in Q4 2023, selling an estimated $35.9M.
- Ray Dalio's ten largest holdings make up 31% of its $17.9B portfolio in Q4 2023.
- Ray Dalio opened 87 new positions and closed 85 in Q4 2023.
- Ray Dalio's portfolio value rose 8% quarter-over-quarter to $17.9B.
Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.